Combining alum with a TLR7-nanoparticle adjuvant enhances vaccine-elicited humoral and cellular immunity
Biomaterials Science · 2026
DOI: 10.1039/d6bm01271j ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Science, 2026. Verfasst von Sijin Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, 78712, USA. qian.yin@austin.utexas.edu. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: University of Texas at Austin, Cancer Prevention and Research Institute of Texas.
Abstract (Originalsprache)
The vaccine adjuvant formulation combining Alum and TLR7-NP broadens antigen-presenting cell engagement, enhances cross-reactive antibody responses, and strengthens CD4 + and CD8 + T cell immunity.
Autor:innen und Institutionen
- Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, 78712, USA. qian.yin@austin.utexas.edu.
- Texas Materials Institute, University of Texas at Austin, Austin, TX, 78712, USA.
Förderung
- University of Texas at Austin
- Cancer Prevention and Research Institute of Texas
Zitieren
APA
Huang, S., Li, Q., Patel, R. D., Kang, X., & Yin, Q. (2026). Combining alum with a TLR7-nanoparticle adjuvant enhances vaccine-elicited humoral and cellular immunity. Biomaterials Science. https://doi.org/10.1039/d6bm01271j
Vancouver
Huang S, Li Q, Patel RD, Kang X, Yin Q. Combining alum with a TLR7-nanoparticle adjuvant enhances vaccine-elicited humoral and cellular immunity. Biomaterials Science. 2026. doi:10.1039/d6bm01271j
BibTeX
@article{Huang2026,
author = {Huang, Sijin and Li, Qiuya and Patel, Riya D and Kang, Xiaowo and Yin, Qian},
title = {Combining alum with a TLR7-nanoparticle adjuvant enhances vaccine-elicited humoral and cellular immunity},
journal = {Biomaterials Science},
year = {2026},
doi = {10.1039/d6bm01271j}
}
EUVIMED